Related Experiment Video

Updated: Aug 18, 2026

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
11:28

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically

Published on: September 9, 2015

[In vitro activities of sulopenem, a new parenteral penem, against anaerobes]

K Watanabe1, N Kato, K Tanaka-Bandoh

  • 1Institute of Anaerobic Bacteriology, Gifu University School of Medicine.

The Japanese Journal of Antibiotics
|April 1, 1996
PubMed

Insights

Sulopenem, a new parenteral penem antibiotic, demonstrates broad-spectrum activity against anaerobic bacteria, including resistant strains. In vivo studies showed efficacy comparable to imipenem/cilastatin without inducing Clostridium difficile overgrowth.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Anaerobic bacteria and fastidious aerobic bacteria pose significant challenges in clinical settings.
  • Novel antibiotics are needed to combat resistant strains and improve treatment outcomes.

Purpose of the Study:

  • To evaluate the in vitro and in vivo activities of sulopenem against anaerobic and fastidious aerobic bacteria.
  • To compare sulopenem's efficacy and spectrum with established antibiotics like imipenem.

Main Methods:

  • In vitro susceptibility testing against 66 reference strains and 392 clinical isolates.
  • Assessment of resistance to beta-lactamases, including oxyiminocephalosporinase and metallo-beta-lactamase.
  • In vivo efficacy studies in mice for intra-abdominal infection and Clostridium difficile overgrowth.

Main Results:

  • Sulopenem exhibited broad-spectrum activity against anaerobic bacteria, with MICs ≤ 0.78 µg/ml for most strains.
  • It showed higher activity than imipenem against Bacteroides fragilis and other key anaerobic species.
  • Sulopenem demonstrated stability against certain beta-lactamases and was effective in a murine intra-abdominal infection model.

Conclusions:

  • Sulopenem is a potent parenteral penem with broad-spectrum activity against clinically relevant anaerobic bacteria.
  • Its stability against specific beta-lactamases and in vivo efficacy support its potential as a therapeutic agent.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro11:52

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro

Published on: April 21, 2023

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...